Literature DB >> 24713987

Epithelial-to-mesenchymal transition in renal neoplasms.

Huiying He1, Cristina Magi-Galluzzi.   

Abstract

Epithelial-to-mesenchymal transition (EMT) describes a phenotypical change induced in epithelial cells that lose their cell-cell basement membrane contacts and their structural polarity to become spindle-shaped and morphologically similar to mesenchymal/myofibroblast cell. The abnormal induction of EMT has been demonstrated to contribute to cancer dissemination and progression. Renal cell carcinoma (RCC) with sarcomatoid differentiation (sarcomatoid RCC) represents a good example of EMT both morphologically and immunohistochemically. Early spindle cell changes can at times be identified in RCC and likely represent an early step toward EMT. Herein, we present a review of the current understanding of EMT in renal neoplasms including some known signaling regulation, the association of sarcomatoid differentiation in RCC with aggressive behavior and dismal prognosis, and EMT-related tumor biology in sarcomatoid RCC. A better perception of the EMT may contribute toward an improved understanding of the development of sarcomatoid RCC. In addition, a distinct signature for sarcomatoid RCC may have utility in the differential diagnosis for prognostic stratification as well as in identifying novel genes and pathway targets for therapeutic intervention.

Entities:  

Mesh:

Year:  2014        PMID: 24713987     DOI: 10.1097/PAP.0000000000000018

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  24 in total

1.  Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation.

Authors:  Mehrad Adibi; Arun Z Thomas; Leonardo D Borregales; Megan M Merrill; Rebecca S Slack; Hsiang-Chun Chen; Kanishka Sircar; Paari Murugan; Pheroze Tamboli; Eric Jonasch; Nizar M Tannir; Surena F Matin; Christopher G Wood; Jose A Karam
Journal:  Urol Oncol       Date:  2015-05-23       Impact factor: 3.498

2.  JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management.

Authors:  Sounak Gupta; John C Cheville; Achim A Jungbluth; Yanming Zhang; Lei Zhang; Ying-Bei Chen; Satish K Tickoo; Samson W Fine; Anuradha Gopalan; Hikmat A Al-Ahmadie; Sahussapont J Sirintrapun; Kyle A Blum; Christine M Lohse; A Ari Hakimi; R Houston Thompson; Bradley C Leibovich; Michael F Berger; Maria E Arcila; Dara S Ross; Marc Ladanyi; Cristina R Antonescu; Victor E Reuter
Journal:  Mod Pathol       Date:  2019-04-17       Impact factor: 7.842

3.  Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.

Authors:  Hiroshi Hirata; Yuji Hinoda; Varahram Shahryari; Guoren Deng; Koichi Nakajima; Z Laura Tabatabai; Nobuhisa Ishii; Rajvir Dahiya
Journal:  Cancer Res       Date:  2015-01-19       Impact factor: 12.701

Review 4.  Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy.

Authors:  Francesco Piva; Matteo Giulietti; Matteo Santoni; Giulia Occhipinti; Marina Scarpelli; Antonio Lopez-Beltran; Liang Cheng; Giovanni Principato; Rodolfo Montironi
Journal:  Mol Diagn Ther       Date:  2016-04       Impact factor: 4.074

Review 5.  Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.

Authors:  Maximilian Seles; Georg C Hutterer; Tobias Kiesslich; Karl Pummer; Ioana Berindan-Neagoe; Samantha Perakis; Daniela Schwarzenbacher; Michael Stotz; Armin Gerger; Martin Pichler
Journal:  Int J Mol Sci       Date:  2016-04-15       Impact factor: 5.923

6.  Eukaryotic Translation Initiation Factor 3b is both a Promising Prognostic Biomarker and a Potential Therapeutic Target for Patients with Clear Cell Renal Cell Carcinoma.

Authors:  Yuanwei Zang; Xiang Zhang; Lei Yan; Gangli Gu; Dawei Li; Yongzhen Zhang; Liang Fang; Shanshan Fu; Juchao Ren; Zhonghua Xu
Journal:  J Cancer       Date:  2017-09-02       Impact factor: 4.207

Review 7.  Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma.

Authors:  Prashanth Prithviraj; Nuzhat Ahmed; Revati Sharma; Elif Kadife; Mark Myers; George Kannourakis
Journal:  J Exp Clin Cancer Res       Date:  2021-06-07

8.  Hydrogen Sulfide Inhibits Transforming Growth Factor-β1-Induced EMT via Wnt/Catenin Pathway.

Authors:  Lin Guo; Wen Peng; Jie Tao; Zhen Lan; Hongya Hei; Lulu Tian; Wanma Pan; Li Wang; Xuemei Zhang
Journal:  PLoS One       Date:  2016-01-13       Impact factor: 3.240

9.  Snail heterogeneity in clear cell renal cell carcinoma.

Authors:  Laura Zaldumbide; Asier Erramuzpe; Rosa Guarch; Rafael Pulido; Jesús M Cortés; José I López
Journal:  BMC Cancer       Date:  2016-03-08       Impact factor: 4.430

10.  Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma.

Authors:  Hana Mlcochova; Tana Machackova; Anja Rabien; Lenka Radova; Pavel Fabian; Robert Iliev; Katerina Slaba; Alexandr Poprach; Ergin Kilic; Michal Stanik; Martina Redova-Lojova; Marek Svoboda; Jan Dolezel; Rostislav Vyzula; Klaus Jung; Ondrej Slaby
Journal:  Sci Rep       Date:  2016-08-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.